Ayala Pharmaceuticals Inc. (ADXS)
OTCMKTS: ADXS · Delayed Price · USD
0.540
-0.032 (-5.59%)
Apr 23, 2024, 11:09 AM EDT - Market closed
Ayala Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Capitalization | 23 | 4 | 2 | 20 | 21 | 13 | 29 | 139 | 289 | 314 | 55 | Upgrade
|
Market Cap Growth | - | 83.10% | -89.14% | -5.57% | 63.10% | -55.32% | -79.02% | -51.89% | -7.86% | 471.37% | 190.24% | Upgrade
|
Enterprise Value | 26 | 7 | -23 | -21 | 2 | -3 | -15 | 115 | 502 | 247 | 37 | Upgrade
|
PE Ratio | 0 | -0.08 | -0.15 | -1.12 | -0.80 | -0.73 | -0.44 | -1.49 | -3.93 | -6.68 | -3.32 | Upgrade
|
PS Ratio | 1770.93 | 307.38 | 8.73 | 6.20 | 84.09 | 5.59 | 4.82 | 11.57 | 72.41 | - | 54.95 | Upgrade
|
PB Ratio | 0 | -0.16 | 0.09 | 0.52 | 0.70 | 0.90 | 1.21 | 2.57 | 2.42 | 2.72 | 2.66 | Upgrade
|
P/FCF Ratio | - | -0.14 | -0.14 | -1.26 | -0.94 | -0.80 | -0.45 | -1.71 | -21.40 | -12.11 | -3.15 | Upgrade
|
P/OCF Ratio | - | -0.14 | -0.14 | -1.30 | -0.97 | -0.87 | -0.47 | -1.81 | -31.89 | -13.01 | -3.23 | Upgrade
|
EV/Sales Ratio | 2035.08 | 571.53 | -92.05 | -6.63 | 8.36 | -1.45 | -2.46 | 9.58 | 125.58 | - | 37.40 | Upgrade
|
EV/EBITDA Ratio | -0.10 | -0.21 | 1.46 | 1.14 | -0.09 | 0.19 | 0.21 | -1.18 | -6.60 | -5.12 | -1.94 | Upgrade
|
EV/EBIT Ratio | -0.09 | -0.21 | 1.43 | 1.09 | -0.08 | 0.19 | 0.20 | -1.17 | -6.55 | -5.09 | -1.92 | Upgrade
|
EV/FCF Ratio | -0.16 | -0.25 | 1.49 | 1.35 | -0.09 | 0.21 | 0.23 | -1.41 | -37.11 | -9.54 | -2.14 | Upgrade
|
Debt / Equity Ratio | -0.34 | -0.34 | 0.06 | 0.00 | 0.20 | 0.02 | 0.10 | 0.11 | 2.80 | 0.00 | 0.00 | Upgrade
|
Debt / EBITDA Ratio | -0.23 | -0.23 | 0.00 | 0.00 | -0.25 | -0.02 | - | - | -4.28 | 0.00 | 0.00 | Upgrade
|
Debt / FCF Ratio | -0.40 | -0.28 | 0.00 | 0.00 | -0.27 | -0.02 | - | - | -24.05 | 0.00 | 0.00 | Upgrade
|
Quick Ratio | 0.20 | 0.20 | 11.05 | 5.37 | 7.79 | 3.24 | 1.93 | 3.58 | 5.58 | 29.08 | 7.12 | Upgrade
|
Current Ratio | 0.30 | 0.30 | 11.18 | 5.49 | 8.46 | 3.34 | 2.21 | 3.89 | 5.77 | 29.36 | 7.55 | Upgrade
|
Asset Turnover | 0.00 | 0.00 | 0.01 | 0.07 | 0.01 | 0.12 | 0.10 | 0.13 | 0.02 | 0 | 0.04 | Upgrade
|
Interest Coverage | 0 | -2.30 | 0 | -72.25 | 0 | 0 | 0 | 0 | 0 | 0 | -3719.51 | Upgrade
|
Return on Equity (ROE) | 196.88% | 196.88% | -60.77% | -45.93% | -87.70% | -123.10% | -276.56% | -172.20% | -61.66% | -40.68% | -80.10% | Upgrade
|
Return on Assets (ROA) | -289.96% | -289.96% | -55.38% | -38.18% | -68.70% | -88.72% | -106.82% | -99.78% | -43.51% | -39.32% | -70.69% | Upgrade
|
Return on Capital (ROIC) | 225.24% | 225.24% | -68.07% | -48.26% | -73.07% | -120.06% | -292.62% | -181.58% | -17.21% | -42.09% | -94.42% | Upgrade
|
Earnings Yield | -208.81% | -1203.02% | -657.96% | -88.91% | -124.41% | -136.40% | -227.82% | -67.13% | -25.43% | -14.98% | -30.08% | Upgrade
|
FCF Yield | -90.89% | -737.87% | -709.55% | -79.14% | -106.64% | -124.81% | -222.53% | -58.59% | -4.67% | -8.26% | -31.78% | Upgrade
|
Buyback Yield / Dilution | -230.97% | -12.70% | -111.61% | -301.14% | -342.75% | -27.13% | -14.48% | -26.31% | -63.84% | -241.36% | Upgrade
| |
Total Shareholder Return | -230.97% | -12.70% | -111.61% | -301.14% | -342.75% | -27.13% | -14.48% | -26.31% | -63.84% | -241.36% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.